Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 7,141–7,160 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Amino Acid Injection 50 g/1000 mL (50 mg/mL) 25 g L-Arginine HCl; 25 g L-Lysine HCl, Single Dose Container, Rx Only Nephron 503B outsourcing facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-988-10

by Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center

Reason
Lack of Assurance of Sterility; bags have potential to leak
Recall initiated
October 9, 2019
Reported by FDA
October 30, 2019
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl 0.1% in 0.9% Sodium Chloride Injection-200 mL Total Dose: (400 mcg/200 mg)/200 mL, Rx Only Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-526-20

by Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center

Reason
GMP Deviations: potential glass contamination
Recall initiated
October 9, 2019
Reported by FDA
October 30, 2019
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only Total Dose: (500 mcg/312.5 mg)/250 mL, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-530-25

by Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center

Reason
GMP Deviations: potential glass contamination
Recall initiated
October 9, 2019
Reported by FDA
October 30, 2019
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chloride Injection-250 mL Total Dose: (500 mcg/156.3 mg)/250 mL, Rx Only, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC 69374-0525-25

by Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center

Reason
GMP Deviations: potential glass contamination
Recall initiated
October 9, 2019
Reported by FDA
October 30, 2019
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Leucovorin Calcium Injection, USP 500 mg*/50 mL (10 mg/mL) 50 mL Single-Dose Vial NDC 50742-464-50 Rx Only Ingenus Pharmaceuticals, LLC. Orlando, FL 32839

by Ingenus Pharmaceuticals Llc

Reason
Crystallization: Presence of particulate matter identified as API crystallization
Recall initiated
October 9, 2019
Reported by FDA
October 23, 2019
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd, Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-284-90

by Jubilant Cadista Pharmaceuticals, Inc.

Reason
CGMP Deviation: Presence of dark brown discoloration on edges of tablets.
Recall initiated
September 4, 2019
Reported by FDA
October 23, 2019
Distribution
Product was distributed to MS, OH, RI, TN and Puerto Rico to distributors and wholesalers who may have further distributed the product to the retail level.

View recall →

Drug Recall Terminated Historical recordClass II

Ascorbic Acid Sterile Injection Solution, 500 mg/mL, 50 mL vial, Non-Corn Source, Rx only, Atlas Pharmaceuticals, LLC, 711 E Carefree Hwy, Suite 107, Phoenix, AZ 85085, NDC 71591-500-50.

by Atlas Pharmaceuticals, LLC

Reason
Labeling: Not Elsewhere Classified; product is labeled as "Non-Corn Source" however the product is from a corn source.
Recall initiated
August 28, 2019
Reported by FDA
October 23, 2019
Distribution
Healthcare facilities/clinics in AZ and CO

View recall →

Drug Recall Terminated Historical recordClass II

Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Entity Amphetamine Product), 20mg, 100-count bottle, RX Only, Distributed by: Aurobindo Pharma USA Inc., Dayton, NJ 08810, NDC 13107-073-01

by Aurobindo Pharma USA Inc.

Reason
Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.
Recall initiated
September 19, 2019
Reported by FDA
October 23, 2019
Distribution
Nationwide in the US

View recall →

Drug Recall Terminated Historical recordClass III

Methylphenidate Hydrochloride Oral Solution 5mg per 5mL, 500 mL Bottle, Sugar Free Alcohol Free, Rx Only, Mfd by: KVK Tech, Inc., Newtown, PA 18940, NDC 10702-0163-50.

by KVK-Tech, Inc.

Reason
Presence of Foreign Substance; Fiber particles.
Recall initiated
October 4, 2019
Reported by FDA
October 23, 2019
Distribution
Nationwide in the U.S.

View recall →

Drug Recall Terminated Historical recordClass II

Fentanyl Citrate USP, Active Pharmaceutical Ingredient, Spectrum Chemical MFG. CORP., Gardena, CA 90248 NDC 49452-0032-06

by Spectrum Laboratory Products

Reason
CGMP Deviations: Received notice from supplier that there is potential glass contamination.
Recall initiated
September 12, 2019
Reported by FDA
October 23, 2019
Distribution
Product was distributed to compounding pharmacies and labs in CA, CO, MD, SC.

View recall →

Drug Recall Terminated Historical recordClass II

Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India NDC 33342-054-07

by Macleods Pharma Usa Inc

Reason
Superpotent
Recall initiated
September 23, 2019
Reported by FDA
October 23, 2019
Distribution
Product was shipped to 8 distributors who may have further distributed the product.

View recall →

Drug Recall Terminated Historical recordClass II

Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60.

by Mylan Laboratories Limited (Sterile Products Division)

Reason
Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.
Recall initiated
October 7, 2019
Reported by FDA
October 16, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass III

Sodium Chloride Injection USP 0.9%, packaged in 1 - 125 mL Ultraject Prefilled Syringe For Power Injection per carton, RFID Technology, Rx Only, Manufactured by: Liebel-Flarshelm Company, LLC., Raleigh, NC 27616; NDC 0019-1188-27.

by GUERBET LLC

Reason
Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.
Recall initiated
September 13, 2019
Reported by FDA
October 16, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Optiray 320 (ioversol) Injection 68%, 320 mg/mL Organically Bound Iodine, packaged in 1 - 100 mL Ultraject Prefilled Syringe For Power Injection per carton, RFID Technology, Rx Only, Manufactured by: Liebel-Flarshelm Company, LLC., Raleigh, NC 27616; NDC 0019-1323-00.

by GUERBET LLC

Reason
Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.
Recall initiated
September 13, 2019
Reported by FDA
October 16, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 mL bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7418-13

by Pfizer Inc.

Reason
Lack of Assurance of Sterility: Bag has the potential to leak.
Recall initiated
October 2, 2019
Reported by FDA
October 16, 2019
Distribution
Nationwide in the United States and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Estradiol tablets, 0.5 mg, 100-count bottles, Rx only, Distributed by Epic Pharma, LLC Laurelton, NY 11413, NDC 42806-087-01

by Epic Pharma, LLC

Reason
Presence of Foreign Tablets/Capsules: Estradiol 1 mg was found in a 100 count bottle of Estradiol 0.5 mg Tablets.
Recall initiated
September 26, 2019
Reported by FDA
October 16, 2019
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass III

Benazepril HCl Tablets, USP 40 mg, 100 count bottles, Rx only, Distributed by Amneal Pharmaceuticals, Bridgewater, NJ NDC 65162-754-10

by Amneal Pharmaceuticals, Inc.

Reason
Presence of Foreign Tablet/Capsule; Promethazine HCl tablet found in the Benazepril HCl bottle
Recall initiated
September 24, 2019
Reported by FDA
October 16, 2019
Distribution
Product was distributed to 13 major distributors throughout the United States who may have further distribute the product.

View recall →

Drug Recall Terminated Historical recordClass II

DrKids Himasal Natural Nasal Saline Solution, packaged in Pre-measured Singe-Use Vials a) 0.5 mL Each (20 count) UPC 37030244608; b) 1.5 mL Each (20 count) UPC 370302446098, Manufactured in USA by: UNIPHARMA, LLC Tamarac, FL 33321

by Unipharma, Llc.

Reason
CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.
Recall initiated
September 23, 2019
Reported by FDA
October 16, 2019
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

DrKids Children's Natural Cough Syrup English Ivy Leaf, packaged in Pre-measured Single-Use Vials 0.17 fl. oz. (5 mL) Each 3.4 fl. oz. (100 mL), Manufactured in USA by: UNIPHARMA, LLC Tamarac, FL 33321 UPC 370302489026

by Unipharma, Llc.

Reason
CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.
Recall initiated
September 23, 2019
Reported by FDA
October 16, 2019
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 52544-692-30

by Teva Pharmaceuticals USA

Reason
GMP Deviation: lot not intended for commercial distribution.
Recall initiated
September 6, 2019
Reported by FDA
October 16, 2019
Distribution
Product was distributed to 42 wholesalers and 11 retailers who may have further distribute the product throughout the United States, including Hawaii and Puerto Rico.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.